Arbutus Biopharma (ABUS) Times Interest Earned (2017 - 2025)
Historic Times Interest Earned for Arbutus Biopharma (ABUS) over the last 9 years, with Q3 2025 value amounting to -$376.48.
- Arbutus Biopharma's Times Interest Earned rose 4907.71% to -$376.48 in Q3 2025 from the same period last year, while for Sep 2025 it was -$429.39, marking a year-over-year increase of 2200.79%. This contributed to the annual value of -$557.07 for FY2024, which is 22738.37% down from last year.
- According to the latest figures from Q3 2025, Arbutus Biopharma's Times Interest Earned is -$376.48, which was up 4907.71% from $53.14 recorded in Q2 2025.
- Arbutus Biopharma's 5-year Times Interest Earned high stood at $53.14 for Q2 2025, and its period low was -$917.82 during Q1 2025.
- In the last 5 years, Arbutus Biopharma's Times Interest Earned had a median value of -$87.94 in 2023 and averaged -$259.31.
- As far as peak fluctuations go, Arbutus Biopharma's Times Interest Earned crashed by 102880.68% in 2023, and later skyrocketed by 10837.17% in 2025.
- Arbutus Biopharma's Times Interest Earned (Quarter) stood at -$37.14 in 2021, then crashed by 96.62% to -$73.02 in 2022, then plummeted by 545.78% to -$471.52 in 2023, then grew by 1.5% to -$464.43 in 2024, then grew by 18.94% to -$376.48 in 2025.
- Its last three reported values are -$376.48 in Q3 2025, $53.14 for Q2 2025, and -$917.82 during Q1 2025.